Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.83, read 2026-10-27
Ethical passes the values gate
Price42.51 USD
Fair value42.60
Our investment reviews on this name
2026-10-11Read Accumulation32.76+29.8% to today ✓Distribution gives way to Accumulation
2026-10-02Read Distribution32.76+29.8% to today Markup gives way to Distribution after a 23% rise in 13 weeks
2026-07-02Read Markup26.68+59.3% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Box, Inc. holds its Accumulation at $42.51. The statistical read favours the sellers, held for 13 days.
As held on the ledger · 2026-10-27
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 13 days
Price at the screen
$42.51
Valuation
61.61 trailing · 24.45 forward price to earnings
Values screen
PASS
Beta
0.72
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
11.88%
Below 33%
Interest-bearing debt is just 11.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
5.61%
Below 33%
Cash held in interest-bearing accounts and securities is 5.6% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
2.10%
Below 5%
Only 2.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Box, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 12%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BOX's ethical verdict changes
Today BOX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 0.2% margin of safety to the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits −6% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cloud storage name still far from profit
Picture a digital filing cabinet that everyone needs yet few pay enough to cover the costs. Box keeps adding users at 14% revenue growth, yet the business still posts a 20% negative profit margin and a startling negative 576% return on equity. The forward multiple of 16.9 times earnings looks reasonable next to analyst targets around 32 dollars, but a weak moat and persistent losses mean the company fails to clear our threshold for opportunity despite clearing the ethical screen.
The gap between the current price near 30 dollars and our fair value of 39 dollars offers little comfort when the underlying economics remain so fragile. Heavy cash burn and thin competitive defences leave little room for error if growth slows or pricing pressure rises. Consensus buy ratings from eight analysts do not change the simple fact that the numbers do not yet support ownership.
Risk sits in the ongoing losses and weak returns, which could worsen if competition intensifies or customers shift to cheaper alternatives. Currency moves and macro spending cuts add further pressure on a business already running at a loss. Analysis, not advice.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BOX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Accumulation$39.48+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 41% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32.
2026-10-18Accumulation$39.48+20.5%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 20.5% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32.
2026-08-25Markup$32.44+0.0%Entry 7
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Markup$32.44+0.0%Entry 6
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Markup$32.44+6.4%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-23Markup$30.48+14.2%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.2% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32.
2026-07-18Markup$26.68+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (8 analysts) rates it buy, with a mean price target of $32.
2026-07-03Markup$26.68+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
